ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
10, 2011 /PRNewswire via COMTEX/ -- ChemoCentryx, Inc. today announced positive preclinical results for its novel CCR2 antagonist at the 44th Annual Meeting of the American Society of Nephrology. CCR2 inhibition in diabetic mice resulted in rapid and

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.